Open-chest epicardial ablation of ventricular tachycardia during a left ventricular assist device implantation: a case report

1. Gopinathannair R, Cornwell WK, Dukes JW, Ellis CR, Hickey KT, Joglar JA, et al. Device

therapy and arrhythmia management in left ventricular assist device recipients: a scien­

tific statement from the American Heart Association. Circulation 2019;139:e967–e989.

2. Anderson RD, Lee G, Virk S, Bennett RG, Hayward CS, Muthiah K, et al. Catheter ab­

lation of ventricular tachycardia in patients with a ventricular assist device: a systematic

review of procedural characteristics and outcomes. JACC Clin Electrophysiol 2019;5:

39–51.

3. Corona S, Naliato M, Tondo C, Casella M, Apostolo A, Agostoni P, et al. Successful open

chest epicardial ablation for refractory ventricular tachycardia in an LVAD recipient.

JACC Case Rep 2021;3:1055–1060.

4. Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Bergin JD, Mahapatra S, et al.

Cryoablation during left ventricular assist device implantation reduces postoperative

ventricular tachyarrhythmias. J Thorac Cardiovasc Surg 2013;145:1207–1213.

5. Patel M, Rojas F, Shabari FR, Simpson L, Cohn W, Frazier OH, et al. Safety and feasibility

of open chest epicardial mapping and ablation of ventricular tachycardia during the per­

iod of left ventricular assist device implantation. J Cardiovasc Electrophysiol 2016;27:

95–101.

6. Moss JD, Oesterle A, Raiman M, Flatley EE, Beaser AD, Jeevanandam V, et al. Feasibility

and utility of intraoperative epicardial scar characterization during left ventricular assist

device implantation. J Cardiovasc Electrophysiol 2019;30:183–192.

7. Shah RL, Hiesinger W, Badhwar N. Open-chest ablation of incessant ventricular tachy­

cardia during left ventricular assist device implantation. JACC Clin Electrophysiol 2020;6:

901–902.

8. Kushnir A, Pallister KH, Chaudhary SB, Cevasco M, Naka Y, Saluja D. High-density sub­

strate and activation mapping of epicardial ventricular tachycardia during left ventricular

assist device implant. HeartRhythm Case Rep 2020;6:690–693.

9. Tankut S, Gosev I, Yoruk A, Younis A, McNitt S, Bjelic M, et al. Intraoperative ventricular

tachycardia ablation during left ventricular assist device implantation in high-risk heart

failure patients. Circ Arrhythm Electrophysiol 2022;15:e010660.

10. Imamura T, Kinugawa K, Shiga T, Endo M, Inaba T, Maki H, et al. Early decision for a left

ventricular assist device implantation is necessary for patients with modifier A. J Artif

Organs 2012;15:301–304.

11. Kormos RL, Cowger J, Pagani FD, Teuteberg JJ, Goldstein DJ, Jacobs JP, et al. The Society

of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes,

and scientific partnerships. J Heart Lung Transplant 2019;38:114–126.

12. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, et al. INTERMACS

profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009;28:

535–541.

13. Fukushima N, Ono M, Saiki Y, Sawa Y, Nunoda S, Isobe M. Registry report on heart

transplantation in Japan (June 2016). Circ J 2017;81:298–303.

14. Gopinathannair R, Pothineni NVK, Trivedi JR, Roukoz H, Cowger J, Ahmed MM, et al.

Amiodarone use and all-cause mortality in patients with a continuous-flow left ventricu­

lar assist device. J Am Heart Assoc 2022;11:e023762.

15. Japan Organ Transplant Network, https://www.jotnw.or.jp/

Downloaded from https://academic.oup.com/ehjcr/article/7/7/ytad277/7205823 by Natural Science Lib of Kobe Univ user on 20 July 2023

Funding: The Section of Arrhythmia is supported by an endowment

from Abbott JAPAN, Boston Scientific JAPAN, and Medtronic Japan.

KF belongs to the Section. K.F. has received a scholarship donation

from Biotronik.

K. Fukuzawa et al.

...